Tessara Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $3M

  • Investors
  • 2

Tessara Therapeutics General Information

Description

Developer of three-dimensional (3D) neural micro-tissues intended for therapeutic and drug screening applications. The company aims to replace inadequate and expensive existing cell and animal models and its micro-tissues are designed to secrete therapeutic factors to address key deficiencies associated with Parkinson's disease pathophysiology and other neurological diseases, enabling the medical community to reduce costs and failures in neuroscience drug development to date.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 40 City Road
  • Southbank
  • Melbourne, Victoria 3006
  • Australia
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 40 City Road
  • Southbank
  • Melbourne, Victoria 3006
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tessara Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Dec-2024 $3M Completed Generating Revenue
2. Angel (individual) 28-Mar-2022 Completed Generating Revenue
1. Angel (individual) 07-May-2020 $2.7M $2.7M Completed Generating Revenue
To view Tessara Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tessara Therapeutics Patents

Tessara Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2026908645-A0 Improved cellularised hydrogel compositions and related methods Pending 16-Oct-2026
AU-2025904886-A0 Improved cellularised hydrogel compositions and related methods Pending 17-Oct-2025
AU-2025900783-A0 Integrated biosensor compositions and methods Inactive 13-Mar-2025
AU-2024903364-A0 Improved cellularised hydrogel compositions and related methods Pending 18-Oct-2024
AU-2024900695-A0 Integrated biosensor compositions and methods Pending 15-Mar-2024
To view Tessara Therapeutics’s complete patent history, request access »

Tessara Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tessara Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cicada Innovations Accelerator/Incubator
Jumar Bioincubator Accelerator/Incubator
To view Tessara Therapeutics’s complete investors history, request access »

Tessara Therapeutics FAQs

  • When was Tessara Therapeutics founded?

    Tessara Therapeutics was founded in 2018.

  • Where is Tessara Therapeutics headquartered?

    Tessara Therapeutics is headquartered in Melbourne, Australia.

  • What is the size of Tessara Therapeutics?

    Tessara Therapeutics has 10 total employees.

  • What industry is Tessara Therapeutics in?

    Tessara Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Tessara Therapeutics a private or public company?

    Tessara Therapeutics is a Private company.

  • What is Tessara Therapeutics’s current revenue?

    The current revenue for Tessara Therapeutics is .

  • How much funding has Tessara Therapeutics raised over time?

    Tessara Therapeutics has raised $15.7M.

  • Who are Tessara Therapeutics’s investors?

    Cicada Innovations and Jumar Bioincubator have invested in Tessara Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process